Loss to follow-up of cervical smears without endocervical columnar cells is not disturbing

European Journal of Gynaecological Oncology

Volumn 27, Issue 1, 2006, Pages 42-46

  Tacken, M A J B ^a   Braspenning, J C C ^a   Mulder, J ^a   Hermens, R P M G ^a   Nelen, W L D M ^a   De Bakker, D H ^b   Grol, R P T M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS INSTITUTE FOR HEALTH SERVICES RESEARCH   (Netherlands)

Author keywords

Cervical screening; ECC Smears; Follow up; Mass screening

Indexed keywords

ARTICLE; CANCER GRADING; COLUMNAR EPITHELIUM; EVIDENCE BASED MEDICINE; FEMALE; FOLLOW UP; GENERAL PRACTICE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MASS SCREENING; MEDICAL RECORD; NETHERLANDS; PAPANICOLAOU TEST; PATIENT COMPLIANCE; SQUAMOUS CELL; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY;

ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; COHORT STUDIES; CYTODIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASS SCREENING; MIDDLE AGED; NEEDS ASSESSMENT; PATIENT COMPLIANCE; REGISTRIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TREATMENT REFUSAL; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 33644947719     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Crane L.A.: "Social support and adherence behavior among women with abnormal Pap smears". J. Cancer Educ., 1996, 11, 164.
2. Boyle P., Maisonneuve P., Autier P.: "Update on cancer control in women". Int. J. Gynaecol. Obstet., 2000, 70, 263.
3. Walsh J.M.: "Cervical cancer: developments in screening and evaluation of the abnormal Pap smear". West. J. Med., 1998, 169, 304.
4. Day N.E.: "Screening for cancer of the cervix". J. Epidemiol. Comm. Health, 1989, 43, 103.
5. Sigurdsson K.: "Effect of organized screening on the risk of cervical cancer. Evaluation of screening activity in Iceland, 1964-1991". Int. J. Cancer, 1993, 54, 563.
6. Austoker J.: "Cancer prevention in primary care: screening for cervical cancer". Br. Med. J., 1994, 309, 241.
7. Coleman D., Day N., Douglas G., Farmery E., Lynge E., Philip J. et al.: "European guidelines for quality assurance in cervical cancer screening. Europe against cancer programme". Eur. J. Cancer, 1993, 29A (suppl. 4), S1.
8. Marcus A.C., Crane L.A., Kaplan C.P., Reading A.E., Savage E., Gunning J. et al.: "Improving adherence to screening follow-up among women with abnormal pap smears: results from a large clinic-based trial of three intervention strategies". Med. Care, 1992, 30, 216.
9. Marcus A.C., Kaplan C.P., Crane L.A., Berek J.S., Bernstein G., Gunning J.E. et al.: "Reducing loss-to-follow-up among women with abnormal Pap smears. Results from a randomized trial testing an intensive follow-up protocol and economic incentives". Med. Care, 1998, 36, 397.
10. Michielutte R., Dignan M., Bahnson J., Wells H.B.: "The Forsyth County Cervical Prevention Project-11. Compliance with screening follow-up of abnormal cervical smears". Health Educ. Res., 1994, 9, 421.
11. Holowaty P., Miller A.B., Rohan T., To T.: "Natural history of dysplasia of the uterine cervix". J. Natl. Cancer Inst., 1999, 91, 252.
12. Bos A.B., van Ballegooijen M., van den Akker-van Marle E.M., Hanselaar A.G., van Oortmarssen G.J., Habbema J.D.: "Endocervical Status is not predictive of the incidence of cervical cancer in the years after negative smears". Am. J. Clin. Pathol., 2001, 115, 851.
13. Mitchell H., Medley G.: "Influence of endocervical status on the cytologic prediction of cervical intraepithelial neoplasia". Acta Cytol., 1992, 36, 875.
14. Mitchell H., Medley G.: "Cytological reporting of cervical abnormalities according to endocervical status". Br. J. Cancer, 1993, 67, 585.
15. Mitchell H.S.: "Longitudinal analysis of histologic high-grade disease after negative cervical cytology according to endocervical status". Cancer Cytopathology, 2001, 93, 237.
16. Ballegooijen van M., Hermens R.: "Cervical cancer screening in the Netherlands". Eur. J. Cancer, 2000, 36, 2244.
17. Solomon D., Davey D., Kurman R., Moriarty A., O'Connor D., Prey M. et al.: "The 2001 Bethesda System; terminology for reporting results of cervical cytology". JAMA, 2002, 287, 2114.
18. Kavanagh A.M., Broom D.H.: "Women's understanding of abnormal cervical smear test results: a qualitative interview study". Br. Med. J., 1997, 314, 1388.
19. Wilkinson C., Jones J.M., McBride J.: "Anxiety caused by abnormal result of cervical smear test: a controlled trial". Br. Med. J., 1990, 300, 440.
20. Stewart D.E., Lickrish G.M., Sierra S., Parkin H.: "The effect of educational brochures on knowledge and emotional distress in women with abnormal Papanicolaou smears". Obstet. Gynecol., 1993, 81, 280.
21. Somerset M., Peters T.J.: "Intervening to reduce anxiety for women with mild dyskaryosis: do we know what works and why?". J. Adv. Nurs., 1998, 28, 563.
22. Tacken M.A.J.B., Braspenning J.C.C., Berende A., Hak E., Bakker D.H., de Groenewegen P.P. et al.: "Vaccination of high-risk patients against influenza: impact on primary care contact rates during epidemics. Analysis of routinely collected data". Vaccine, 2004, 22, 2985.
23. Tacken M., Braspenning J., Spreeuwenberg P., van den Hoogen H., van Essen G., de Bakker D. et al.: "Patient characteristics determine differences in the influenza vaccination rate more so than practice features". Prev. Med., 2002, 35, 401.
24. Kaplan E.L., Meier P.: "Nonparametric estimation from incomplete observation". J. Am. Stat. Assoc., 1958, 53, 457.
25. Kalbfleisch J.D., Prentice L.: "The Statistical Analysis of Failure Time Data". New York: Wiley, 1980.
26. Geijer R.M.M.: "Addendum NHG-Standaard Cervixuitstrijken, Herhalingsadvies vervalt bij uitstrijk zonder endocervicale cellen [Addendum NHG guidelines cervical cancer screening: the follow-up recommendation lapses for ECC- smears]". Huisarts Wet., 2002, 45, 133.
27. McKee D.: "Improving the follow-up of patients with abnormal Papanicolaou smear results". Arch. Fam. Med., 1997, 6, 574.
28. McKee M.D., Lurio J., Marantz P., Burton W., Mulvihill M.: "Barriers to follow-up of abnormal Papanicolaou smears in an urban community health center". Arch. Fam. Med., 1999, 8, 129.
29. Tjalma W.A.A., van Dam P.A., Makar A.P., Cruickshank D.J.: "The clinical value and the cost-effectiveness of follow-up in endometrial cancer patients". Int. J. Gynecol. Cancer, 2004, 14, 931.
30. Sawaya G.F., Kerlikowske K., Lee N.C., Gildengorin G., Washington A.E.: "Frequency of cervical smear abnormalities within 3 years of normal cytology". Obstet. Gynecol., 2000, 96, 219.
31. Siebers A.G., de Leeuw H., Verbeek A.L.M., Hanselaar A.G.J.M.: "Prevalence of squamous abnormalities in women with a recent smear without endocervical cells is lower as compared to women with smears with endocervical cells". Cytopathology, 2003, 14, 58.
32. Weel C. van, Knottnerus J.A.: "Evidence-based interventions and comprehensive treatment". Lancet, 1999, 353, 916.